Get the Stockscreener App
12.39
4.12%
0.49
After Hours:
12.45
0.06
+0.48%
Benitec Biopharma Inc stock is traded at $12.39, with a volume of 34,818.
It is up +4.12% in the last 24 hours and down -3.05% over the past month.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
See More
Previous Close:
$11.90
Open:
$11.97
24h Volume:
34,818
Relative Volume:
0.32
Market Cap:
$325.24M
Revenue:
$59,000
Net Income/Loss:
$-21.81M
P/E Ratio:
-1.1313
EPS:
-10.9518
Net Cash Flow:
$-18.07M
1W Performance:
+7.51%
1M Performance:
-3.05%
6M Performance:
+21.47%
1Y Performance:
+34.09%
1-Day Range:
$11.29
$12.46
1-Week Range:
$11.13
$12.46
52-Week Range:
$8.06
$17.15
Benitec Biopharma Inc Stock (BNTC) Company Profile
Name
Benitec Biopharma Inc
Sector
Industry
Phone
(510) 780-0819
Address
3940 TRUST WAY, HAYWARD, CA
Compare BNTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
12.39 | 312.38M | 59,000 | -21.81M | -18.07M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Initiated | TD Cowen | Buy |
| Dec-16-24 | Initiated | H.C. Wainwright | Buy |
| Dec-13-24 | Initiated | Robert W. Baird | Outperform |
| Oct-16-24 | Initiated | Oppenheimer | Outperform |
| Sep-12-24 | Initiated | Guggenheim | Buy |
| Jul-22-24 | Initiated | Leerink Partners | Outperform |
| Jun-13-24 | Initiated | Piper Sandler | Overweight |
| Oct-05-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Apr-20-20 | Initiated | Ladenburg Thalmann | Buy |
| Feb-26-16 | Downgrade | Maxim Group | Buy → Hold |
| Dec-31-15 | Reiterated | Maxim Group | Buy |
| Sep-16-15 | Reiterated | Maxim Group | Buy |
View All
Benitec Biopharma Inc Stock (BNTC) Latest News
What data driven models say about Benitec Biopharma Inc.’s futureFree Secure Return Focused Investment Plan - Newser
Should you hold or exit Benitec Biopharma Inc. nowDaily Market Momentum Summary and Strategy - Newser
A | How Benitec Biopharma Inc. stock performs during market volatilityDouble Your Investment Fast - newsyoung.net
Benitec Biopharma Limited (NASDAQ:BNTC) Receives Average Rating of “Buy” from Brokerages - Defense World
How Benitec Biopharma Inc. stock performs during market volatilityStable Swing Setup with Safety Analysis - Newser
Real time scanner hits for Benitec Biopharma Inc. explainedFree Watchlist for Low Risk High Return - Newser
Will Benitec Biopharma Inc. continue its uptrendReliable Setup Screener with Low Risk - Newser
Price Floor Holding on Benitec Biopharma Inc. — Rebound PossibleLow Risk Buy Zone Opportunity Watch Ongoing - metal.it
Predicting Benitec Biopharma Inc. trend using moving averagesSmart Trade Forecast Based on Neural Logic - Newser
Tools to assess Benitec Biopharma Inc.’s risk profileEntry Zone Watchlist With Momentum Focus - Newser
Will Benitec Biopharma Inc. Stock Benefit from AI and Green Energy TrendsFree Entry and Exit Strategy Optimizer Tool - Newser
Why Benitec Biopharma Inc. is moving todayWeekly Breakout Forecast with Entry Zones - Newser
What to do if you’re stuck in Benitec Biopharma Inc.Entry Optimization Guide with Volume Analysis - Newser
Does Benitec Biopharma Inc. stock pay reliable dividendsWeekly Movement Forecast With Chart Signals - Newser
What makes Benitec Biopharma Inc. stock price move sharplyFree AI-Powered Trade Planning with Indicators - Newser
Does Benitec Biopharma Inc. fit your quant trading modelAI Pattern Recognition and Trade Prediction - Newser
News impact scoring models applied to Benitec Biopharma Inc.Free Short Term Trading Opportunity Watch - Newser
Why Benitec Biopharma Inc. stock attracts strong analyst attentionSummary of Long-Term Buy Zone Stocks - Newser
Benitec Biopharma Sees Bullish Signal with KDJ Golden Cross and Bullish Marubozu Pattern. - AInvest
Will a bounce in Benitec Biopharma Inc. offer an exitFree Low Risk Equity Screener With Results - Newser
Can you recover from losses in Benitec Biopharma Inc.Trade Safety Matrix for Conservative Traders - Newser
How strong is Benitec Biopharma Inc. company’s balance sheetIdentify winners with top-tier analysis - Jammu Links News
What catalysts could drive Benitec Biopharma Inc. stock higher in 2025Triple-digit returns - Jammu Links News
Benitec Biopharma Inc Stock (BNTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.91%
3.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):